Summary
The genetic investigation of diseases and eHealth are a priority of the Smart Specialization Strategy of Cyprus. The strategy can best be served by creating a Centre of Excellence (CoE) with two pillars: a) A contemporary Biobank research infrastructure that incorporates eHealth; b) a state-of-the-art research facility to support the Cyprus Human Genome Project and drive translational research, focused on genetic diseases, thus enhancing the European Research Area.
Biobanks are organized collections of medical records and biospecimens, aimed to support biomedical research, serving as repositories and distribution centers. Biobanking and genomics infrastructures in Cyprus are lagging behind of European levels, thus limiting the prospects for research and innovation potential. The CY-Biobank shall upgrade the existing infrastructure, implementing high standard procedures and quality management systems for safeguarding data and material of the highest trustworthiness, for downstream investigations. The CoE will embrace the entire research community of Cyprus and serve as an incubator for innovative ideas and as a tertiary medical and educational institute for the rare monogenic and frequent complex disorders, aimed at better patient care and precision medicine. The CY-Biobank will adopt a patient-centric approach showing respect to sensitive ethical, legal and social issues, with the involvement of all stakeholders in the medical and patients’ communities. The CoE aspires also to play a broader role by forming the MediEuro Network with countries in the Mediterranean and the Middle East, thus complementing efforts for bridging EU to this part of the world. The Advanced Partners are the Medical University of Graz that coordinated the preparatory phase of the project for Biobanking & BioMolecular resources Research Infrastructure (BBMRI) and its subsequent European Research Infrastructure Consortium, BBMRI-ERIC, which represents the largest family of Biobanks in Europe.
Biobanks are organized collections of medical records and biospecimens, aimed to support biomedical research, serving as repositories and distribution centers. Biobanking and genomics infrastructures in Cyprus are lagging behind of European levels, thus limiting the prospects for research and innovation potential. The CY-Biobank shall upgrade the existing infrastructure, implementing high standard procedures and quality management systems for safeguarding data and material of the highest trustworthiness, for downstream investigations. The CoE will embrace the entire research community of Cyprus and serve as an incubator for innovative ideas and as a tertiary medical and educational institute for the rare monogenic and frequent complex disorders, aimed at better patient care and precision medicine. The CY-Biobank will adopt a patient-centric approach showing respect to sensitive ethical, legal and social issues, with the involvement of all stakeholders in the medical and patients’ communities. The CoE aspires also to play a broader role by forming the MediEuro Network with countries in the Mediterranean and the Middle East, thus complementing efforts for bridging EU to this part of the world. The Advanced Partners are the Medical University of Graz that coordinated the preparatory phase of the project for Biobanking & BioMolecular resources Research Infrastructure (BBMRI) and its subsequent European Research Infrastructure Consortium, BBMRI-ERIC, which represents the largest family of Biobanks in Europe.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/857122 |
| Start date: | 01-10-2019 |
| End date: | 30-09-2027 |
| Total budget - Public funding: | 14 999 976,25 Euro - 14 999 975,00 Euro |
Cordis data
Original description
The genetic investigation of diseases and eHealth are a priority of the Smart Specialization Strategy of Cyprus. The strategy can best be served by creating a Centre of Excellence (CoE) with two pillars: a) A contemporary Biobank research infrastructure that incorporates eHealth; b) a state-of-the-art research facility to support the Cyprus Human Genome Project and drive translational research, focused on genetic diseases, thus enhancing the European Research Area.Biobanks are organized collections of medical records and biospecimens, aimed to support biomedical research, serving as repositories and distribution centers. Biobanking and genomics infrastructures in Cyprus are lagging behind of European levels, thus limiting the prospects for research and innovation potential. The CY-Biobank shall upgrade the existing infrastructure, implementing high standard procedures and quality management systems for safeguarding data and material of the highest trustworthiness, for downstream investigations. The CoE will embrace the entire research community of Cyprus and serve as an incubator for innovative ideas and as a tertiary medical and educational institute for the rare monogenic and frequent complex disorders, aimed at better patient care and precision medicine. The CY-Biobank will adopt a patient-centric approach showing respect to sensitive ethical, legal and social issues, with the involvement of all stakeholders in the medical and patients’ communities. The CoE aspires also to play a broader role by forming the MediEuro Network with countries in the Mediterranean and the Middle East, thus complementing efforts for bridging EU to this part of the world. The Advanced Partners are the Medical University of Graz that coordinated the preparatory phase of the project for Biobanking & BioMolecular resources Research Infrastructure (BBMRI) and its subsequent European Research Infrastructure Consortium, BBMRI-ERIC, which represents the largest family of Biobanks in Europe.
Status
SIGNEDCall topic
WIDESPREAD-01-2018-2019Update Date
17-05-2024
Images
No images available.
Geographical location(s)
